Beckman Coulter buys Cogenics for $17m

Related tags Gene expression Molecular biology Genetics Gene Clinical data

Clinical Data is to sell Cogenics division, which provides services including sequencing and gene expression, to Beckman Coulter’s Agencourt Biosciences' business for $17m.

The deal has been described as a “key element​” of Clinical Data’s efforts to sell its non-core assets and focus its resources on its two late-stage targeted therapeutic programmes.

Susan Evans, vice president and general manager of Agencourt, said: "We are excited about the new opportunities and confident that these combined offerings will enable us to meet the full spectrum of service requirements -- sequencing, genotyping, gene expression, and DNA and RNA extraction -- for researchers around the world​."

Related topics Markets & Regulations

Related news

Follow us

Webinars

Headlines